Testing effectiveness (Phase 2)Study completedNCT03682276
What this trial is testing
Safety and Bioactivity of Ipilimumab and Nivolumab Combination Prior to Liver Resection in Hepatocellular Carcinoma
Who this might be right for
Hepatocellular Carcinoma
Imperial College London 33